No Detail Found!

Carcinoembryonic Antigen (CEA) and Beta Human Chorionic Gonadotropin (Beta-hCG) as Markers in Breast Cancer.

Author(s)
S. M. Baig Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
S. Khan Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
S. Anjum Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
A. Khanum Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
M. Z. Haider Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
M. H. Qazi Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
P. Zaidi Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
N. A. Kizilbash Biological Sciences Department, Quaid-e- Azam, University, Islamabad, Pakistan; Nuclear Medical Oncology Radiotherapy Institute, Islamabad, Pakistan
Abstract
Serum tumour markers, carcinoembryonic antigen (CEA) and beta human chorionic gonadotropin (13-hCG) were studied in 65 postmenopausal and 49 premenopausal postoperative breast cancer patients with stage I, II, Ill AND IV. Serum levels of these tumour markers were assessed before and during chemotherapy and/or radiotherapy. Serum CEA concentration was significantly higher (5 ng/ml) in 7.9% (6/76) of patients with local and 60.53% (23/38) of patients with advanced breast cancer (P) compared to controls. The concentration offi-hCG also increased (7 mIU) in 25% (19/76) and 36.8% (14/38) of patients without and with metastatic disease, respectively (P.05). Following unilateral mastectomy serial monitoring of these two tumour markers was carried out in 82 patients before and after the initiation of therapy. Five distinct patterns of marker levels were observed. In three patterns the marker levels increased, decreased and remained unchanged during disease progression, regression and stationary clinical state. Whereas, the other two patterns were paradoxical to the disease. CEA and P-hCG serum levels in patients with metastatic breast cancer correlated with the extent of disease and postoperative values obtained before and after the initiation of therapy were found to be clinically useful markers which could be utilized for prognostic purposes.
Publication Details
Page(s) 71-76
DOI DOI not available
Published Journal: Pakistan Journal of Zoology, Volume: 24, Issue: 1, Year: 1992

Request the full text from PASTIC

Keywords
Breast cancer, Carcinoembryonic antigen, Beta Human Chorionic Gonadotropin
0

Citations

0

Downloads

71

Views